JPMorgan Chase & Co’s Vigil Neuroscience VIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.16M | Buy |
396,926
+396,544
| +103,807% | +$3.15M | ﹤0.01% | 3032 |
|
|
2025
Q1 | $680 | Hold |
382
| – | – | ﹤0.01% | 5793 |
|
|
2024
Q4 | $649 | Sell |
382
-32
| -8% | -$54 | ﹤0.01% | 5725 |
|
|
2024
Q3 | $1.41K | Sell |
414
-8,723
| -95% | -$29.7K | ﹤0.01% | 5614 |
|
|
2024
Q2 | $36.5K | Buy |
9,137
+2,021
| +28% | +$8.08K | ﹤0.01% | 5007 |
|
|
2024
Q1 | $24.3K | Sell |
7,116
-3,299
| -32% | -$11.3K | ﹤0.01% | 5187 |
|
|
2023
Q4 | $35.2K | Hold |
10,415
| – | – | ﹤0.01% | 5116 |
|
|
2023
Q3 | $56.1K | Sell |
10,415
-2,390
| -19% | -$12.9K | ﹤0.01% | 4864 |
|
|
2023
Q2 | $120K | Buy |
+12,805
| New | +$120K | ﹤0.01% | 4553 |
|
|
2022
Q4 | – | Sell |
-2
| Closed | – | – | 5953 |
|
|
2022
Q3 | $0 | Sell |
2
-212
| -99% | – | ﹤0.01% | 5842 |
|
|
2022
Q2 | $1K | Sell |
214
-2,934
| -93% | -$13.7K | ﹤0.01% | 5519 |
|
|
2022
Q1 | $22K | Buy |
+3,148
| New | +$22K | ﹤0.01% | 5247 |
|